FIGURE 2.

Low diagram of patients included in the study, i.e. patients switching from LET to MET (turquoise), patients switching from LET to HET (dark bue) and controls (yellow). DMT, disease modifying therapy; HET, high‐efficacy treatment; n, number; MET, medium‐efficacy treatment; PPMS, primary progressive multiple sclerosis; SPMS, secondary progressive multiple sclerosis; SVK, Schweizerischer Verband für Gemeinschaftsaufgaben der Krankenversicherer (Swiss Federation for Common Tasks of Health Insurances).